Comparative Pharmacology
Head-to-head clinical analysis: CHLORHEXIDINE GLUCONATE versus GAMOPHEN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHLORHEXIDINE GLUCONATE versus GAMOPHEN.
CHLORHEXIDINE GLUCONATE vs GAMOPHEN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cationic bisbiguanide that disrupts microbial cell membranes by binding to negatively charged cell wall components, increasing permeability and causing leakage of cytoplasmic contents; also inhibits bacterial enzymes and precipitates cytoplasmic constituents.
Gamophen contains chlorhexidine gluconate, a cationic bisbiguanide that disrupts microbial cell membranes by binding to negatively charged phosphate groups on bacterial cell walls, leading to leakage of intracellular contents and cell death. It also inhibits bacterial enzymes and has broad-spectrum antimicrobial activity against gram-positive and gram-negative bacteria, fungi, and some viruses.
Oral rinse: 15 mL of 0.12% solution swished in mouth for 30 seconds twice daily; topical: apply 2% cream or lotion to affected area 2-3 times daily.
GAMOPHEN is not a recognized pharmaceutical drug. Please verify the drug name.
None Documented
None Documented
Terminal half-life approximately 12-24 hours; may be prolonged in hepatic impairment.
Terminal elimination half-life is 18-32 hours in adults, prolonged in renal impairment (up to 60 hours in severe cases).
Primarily renal (10-30% unchanged) and biliary/fecal (majority as metabolites).
Primarily renal excretion of unchanged drug (50-70%) and glucuronide conjugates; biliary/fecal elimination accounts for <10%.
Category C
Category C
Antiseptic
Antiseptic